Trial intelligence / Profile preview

Effect of Proton Pump Inhibitors on the Duodenal Microbiome in Functional Dyspepsia

2017-004355-23Phase 4Completed

Sponsor
Targid
Start
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of pantoprazole in functional dyspepsia (FD), sponsored by Targid. Primary endpoints: Microbiota composition of the duodenum, Microbiota composition of the feces and 1 more. Started Dec 2017; status: completed.

02

Drugs

pantoprazole
03

Conditions

functional dyspepsia (FD)

Beyond the preview

Go deeper on 2017-004355-23.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-004355-23.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call